{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:Hedgehog",
      "entity_text" : "Hedgehog",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:57469",
      "entity_text" : "Imiquimod",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Imiquimod 5% cream acts as a topical immune response modifier promoting a Th-1 immune response enhancing the removal of neoplastic cells and has proven to reduce deregulated Hedgehog (HH)/GLI signal strength independent of Toll like receptor signaling, which makes it a valuable adjuvant topical therapy for the treatment of basal cell carcinoma.",
  "reading_complete" : "2020-08-04T12:16:46Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:15:31Z",
  "trigger" : "deregulated",
  "evidence" : [ "Imiquimod 5% cream acts as a topical immune response modifier promoting a Th-1 immune response enhancing the removal of neoplastic cells and has proven to reduce deregulated Hedgehog" ],
  "pmc_id" : "4674454",
  "score" : 0
}